{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:30:53Z","timestamp":1789500653377,"version":"build-2803163510"},"reference-count":98,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007180","name":"Children's Hospital Colorado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009561","name":"American Partnership for Eosinophilic Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020263","name":"Eosinophilic Family Coalition","doi-asserted-by":"publisher","award":["R01 AI045898"],"award-info":[{"award-number":["R01 AI045898"]}],"id":[{"id":"10.13039\/100020263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020263","name":"Eosinophilic Family Coalition","doi-asserted-by":"publisher","award":["R01 AI124355"],"award-info":[{"award-number":["R01 AI124355"]}],"id":[{"id":"10.13039\/100020263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020263","name":"Eosinophilic Family Coalition","doi-asserted-by":"publisher","award":["R01 AI139126"],"award-info":[{"award-number":["R01 AI139126"]}],"id":[{"id":"10.13039\/100020263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020263","name":"Eosinophilic Family Coalition","doi-asserted-by":"publisher","award":["R01 AI148138"],"award-info":[{"award-number":["R01 AI148138"]}],"id":[{"id":"10.13039\/100020263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020263","name":"Eosinophilic Family Coalition","doi-asserted-by":"publisher","award":["T32-HL116275"],"award-info":[{"award-number":["T32-HL116275"]}],"id":[{"id":"10.13039\/100020263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020263","name":"Eosinophilic Family Coalition","doi-asserted-by":"publisher","award":["U19 AI070235"],"award-info":[{"award-number":["U19 AI070235"]}],"id":[{"id":"10.13039\/100020263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jaip.2023.06.035","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T03:47:54Z","timestamp":1687924074000},"page":"2654-2663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Recent Advances in the Treatment of Eosinophilic Esophagitis"],"prefix":"10.1016","volume":"11","author":[{"given":"Amiko M.","family":"Uchida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin M.","family":"Burk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E.","family":"Rothenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn T.","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Spergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.06.035_bib1","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib2","first-page":"1","article-title":"Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring","volume":"30","author":"Collins","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaip.2023.06.035_bib3","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1056\/NEJMra1502863","article-title":"Eosinophilic esophagitis","volume":"373","author":"Furuta","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.06.035_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.gie.2013.10.027","article-title":"A\u00a0phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease","volume":"79","author":"Dellon","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaip.2023.06.035_bib5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.gie.2022.05.013","article-title":"Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference","volume":"96","author":"Aceves","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaip.2023.06.035_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","article-title":"Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system","volume":"62","author":"Hirano","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaip.2023.06.035_bib7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/ajg.2012.468","article-title":"Elemental diet induces histologic response in adult eosinophilic esophagitis","volume":"108","author":"Peterson","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/ACI.0b013e32813aee4a","article-title":"Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients","volume":"7","author":"Spergel","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib9","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3748\/wjg.v12.i15.2328","article-title":"Eosinophilic esophagitis: a newly established cause of dysphagia","volume":"12","author":"Yan","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm.3281","article-title":"Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis","volume":"19","author":"Noti","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2023.06.035_bib11","doi-asserted-by":"crossref","first-page":"G13","DOI":"10.1152\/ajpgi.00290.2015","article-title":"Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice","volume":"310","author":"Judd","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jaip.2023.06.035_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17541-5","article-title":"IL-33 is induced in undifferentiated, non-dividing esophageal epithelial cells in eosinophilic esophagitis","volume":"7","author":"Travers","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2023.06.035_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng.547","article-title":"Common variants at 5q22 associate with pediatric eosinophilic esophagitis","volume":"42","author":"Rothenberg","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2023.06.035_bib14","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2007.10.024","article-title":"IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids","volume":"120","author":"Blanchard","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib15","doi-asserted-by":"crossref","first-page":"G341","DOI":"10.1152\/ajpgi.00404.2017","article-title":"Filaggrin and tight junction proteins are crucial for IL-13\u2013mediated esophageal barrier dysfunction","volume":"315","author":"Wu","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jaip.2023.06.035_bib16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/all.15127","article-title":"Tissue eosinophils express the IL-33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis","volume":"77","author":"Uchida","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.06.035_bib17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2559.2012.4303.x","article-title":"Atopic and non-atopic eosinophilic oesophagitis are distinguished by immunoglobulin E\u2013bearing intraepithelial mast cells","volume":"61","author":"Mulder","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.jaip.2023.06.035_bib18","doi-asserted-by":"crossref","first-page":"eabi5586","DOI":"10.1126\/sciimmunol.abi5586","article-title":"Clonally expanded, GPR15-expressing pathogenic effector T(H)2 cells are associated with eosinophilic esophagitis","volume":"6","author":"Morgan","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib19","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jaci.2022.02.025","article-title":"Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission","volume":"149","author":"Ben-Baruch Morgenstern","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib20","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1172\/JCI125917","article-title":"Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis","volume":"129","author":"Wen","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.06.035_bib21","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1038\/s41467-021-26939-9","article-title":"Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis","volume":"12","author":"Shoda","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2023.06.035_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2022.10.026","article-title":"Breaking down the complex pathophysiology of eosinophilic esophagitis","volume":"130","author":"Underwood","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib23","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1053\/j.gastro.2020.02.038","article-title":"AGA Institute and the Joint Task Force on Allergy\u2014Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib24","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0016-5085(82)80011-5","article-title":"Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis","volume":"83","author":"Winter","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.mayocp.2017.10.022","article-title":"Proton pump inhibitors: review of emerging concerns","volume":"93","author":"Nehra","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2023.06.035_bib26","article-title":"The risks of long-term use of proton pump inhibitors: a critical review","volume":"10","author":"Jaynes","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jaip.2023.06.035_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/apt.14825","article-title":"RNA sequencing confirms similarities between PPI-responsive oesophageal eosinophilia and eosinophilic oesophagitis","volume":"48","author":"Peterson","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2023.06.035_bib28","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/ajg.2013.363","article-title":"Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study","volume":"108","author":"Dellon","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaci.2014.08.043","article-title":"Transcriptome analysis of proton pump inhibitor\u2013responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation","volume":"135","author":"Wen","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib30","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1053\/j.gastro.2021.02.016","article-title":"In esophageal squamous cells from eosinophilic esophagitis patients, Th2 cytokines increase eotaxin-3 secretion through effects on intracellular calcium and a non-gastric proton pump","volume":"160","author":"Odiase","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib31","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jaci.2020.09.039","article-title":"Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors","volume":"147","author":"Rochman","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib32","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.dld.2022.03.006","article-title":"Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis","volume":"54","author":"Thakkar","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaip.2023.06.035_bib33","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.14309\/ajg.0000000000001943","article-title":"Efficacy of a second PPI course after steroid-induced remission in eosinophilic esophagitis refractory to initial PPI therapy","volume":"117","author":"Visaggi","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00535-017-1397-z","article-title":"The role of maintenance therapy in eosinophilic esophagitis: who, why, and how?","volume":"53","author":"Philpott","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib35","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s10620-016-4077-6","article-title":"Management of eosinophilic esophagitis during pregnancy","volume":"61","author":"Burk","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaip.2023.06.035_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.50366","article-title":"Association between proton pump inhibitor use during early pregnancy and risk of congenital malformations","volume":"6","author":"Choi","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2023.06.035_bib37","series-title":"Drugs and Lactation Database (LactMed)","year":"2006"},{"key":"10.1016\/j.jaip.2023.06.035_bib38","series-title":"GI and Liver Disease During Pregnancy: A Practical Approach","author":"Isaacs","year":"2013"},{"key":"10.1016\/j.jaip.2023.06.035_bib39","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.anai.2020.03.020","article-title":"AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis","volume":"124","author":"Hirano","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.anai.2020.03.021","article-title":"Technical review on the management of eosinophilic esophagitis: a report from the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters","volume":"124","author":"Rank","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib41","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1053\/j.gastro.2020.07.039","article-title":"budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis","volume":"159","author":"Straumann","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.gastro.2019.03.025","article-title":"Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial","volume":"157","author":"Lucendo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib43","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.cgh.2012.03.018","article-title":"Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis","volume":"10","author":"Alexander","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.gastro.2014.04.019","article-title":"Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis","volume":"147","author":"Butz","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2468-1253(18)30096-7","article-title":"Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study","volume":"3","author":"Shoda","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib46","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2014.07.034","article-title":"Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients","volume":"13","author":"Wolf","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib47","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cgh.2018.09.005","article-title":"Clinical and molecular factors associated with histologic response to topical steroid treatment in patients with eosinophilic esophagitis","volume":"17","author":"Eluri","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib48","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.cgh.2022.11.004","article-title":"Higher body mass index is associated with decreased treatment response to topical steroids in eosinophilic esophagitis","volume":"21","author":"Ketchem","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.gastro.2019.03.014","article-title":"Efficacy of budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial","volume":"157","author":"Dellon","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2011.02.040","article-title":"Eosinophilic esophagitis: updated consensus recommendations for children and adults","volume":"128","author":"Liacouras","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib51","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1038\/ctg.2017.27","article-title":"Diminishing effectiveness of long-term maintenance topical steroid therapy in PPI non-responsive eosinophilic esophagitis","volume":"8","author":"Eluri","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib52","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MPG.0000000000000848","article-title":"Adrenal suppression in children treated with oral viscous budesonide for eosinophilic esophagitis","volume":"61","author":"Harel","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2023.06.035_bib53","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpeds.2015.11.026","article-title":"Adrenal insufficiency after chronic swallowed glucocorticoid therapy for eosinophilic esophagitis","volume":"170","author":"Golekoh","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2023.06.035_bib54","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MPG.0000000000002537","article-title":"Adrenal insufficiency in children with eosinophilic esophagitis treated with topical corticosteroids","volume":"70","author":"Bose","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2023.06.035_bib55","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/MPG.0000000000003647","article-title":"Impact of dose reduction of topical steroids to manage adrenal insufficiency in pediatric eosinophilic esophagitis","volume":"76","author":"Nistel","year":"2023","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2023.06.035_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cgh.2007.11.008","article-title":"Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children","volume":"6","author":"Schaefer","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib57","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ajg.2013.71","article-title":"ACG clinical guideline: Evidence-based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)","volume":"108","author":"Dellon","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib58","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cgh.2018.05.051","article-title":"Safety and efficacy of budesonide oral suspension maintenance therapy in patients with eosinophilic esophagitis","volume":"17","author":"Dellon","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib59","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ajg.2016.238","article-title":"Swallowed fluticasone propionate is an effective long-term maintenance therapy for children with eosinophilic esophagitis","volume":"111","author":"Andreae","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib60","series-title":"Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma","year":"2007"},{"key":"10.1016\/j.jaip.2023.06.035_bib61","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.cgh.2022.02.013","article-title":"Fluticasone propionate orally disintegrating tablet (APT-1011) for eosinophilic esophagitis: randomized controlled trial","volume":"20","author":"Dellon","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib62","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cgh.2021.04.022","article-title":"Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: results from a phase 3 trial","volume":"20","author":"Hirano","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib63","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/MEG.0b013e32825a6ab4","article-title":"Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission","volume":"19","author":"Netzer","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib64","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4049\/jimmunol.2000973","article-title":"Conserved IFN signature between adult and pediatric eosinophilic esophagitis","volume":"206","author":"Ruffner","year":"2021","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib65","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/apt.17220","article-title":"Oesophageal secretions reveal local food-specific antibody responses in eosinophilic oesophagitis","volume":"56","author":"Pyne","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2023.06.035_bib66","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2014.02.006","article-title":"Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis","volume":"146","author":"Arias","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib67","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.14309\/ajg.0000000000001949","article-title":"Long-term outcomes of the six-food elimination diet and food reintroduction in a large cohort of adults with eosinophilic esophagitis","volume":"117","author":"Zalewski","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib68","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1053\/j.gastro.2012.03.001","article-title":"Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors","volume":"142","author":"Gonsalves","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib69","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jaci.2012.12.664","article-title":"Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease","volume":"131","author":"Lucendo","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib70","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0016-5085(95)90637-1","article-title":"Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula","volume":"109","author":"Kelly","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib71","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jaci.2012.03.023","article-title":"Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis","volume":"129","author":"Henderson","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib72","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/apt.13953","article-title":"Elemental diet decreases inflammation and improves symptoms in adult eosinophilic oesophagitis patients","volume":"45","author":"Warners","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2023.06.035_bib73","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2017.08.038","article-title":"Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: the 2-4-6 study","volume":"141","author":"Molina-Infante","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib74","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.cgh.2021.03.049","article-title":"A\u00a0single-food milk elimination diet is effective for treatment of eosinophilic esophagitis in children","volume":"20","author":"Wechsler","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib75","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1016\/S0016-5085(19)37223-3","article-title":"817 \u2013 Efficacy of 1-food and 4-food elimination diets for pediatric eosinophilic esophagitis in a randomized multi-site study","volume":"156","author":"Kliewer","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib76","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S2468-1253(23)00012-2","article-title":"One-food versus six-food elimination diet therapy for treatment of eosinophilic esophagitis: a multicenter randomized clinical trial","volume":"8","author":"Kliewer","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib77","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.14309\/ajg.0000000000001988","article-title":"Provider beliefs, practices, and perceived barriers to dietary elimination therapy in eosinophilic esophagitis","volume":"117","author":"Chang","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib78","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.cgh.2023.01.019","article-title":"Efficacy of elimination diets in eosinophilic esophagitis: a systematic review and meta-analysis","volume":"21","author":"Mayerhofer","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2023.06.035_bib79","first-page":"CD000133","article-title":"Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child","volume":"9","author":"Kramer","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2023.06.035_bib80","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.anai.2017.11.016","article-title":"Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy","volume":"120","author":"Petroni","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib81","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/modpathol.2014.110","article-title":"Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy","volume":"28","author":"Dellon","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaip.2023.06.035_bib82","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.gie.2017.04.028","article-title":"Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis","volume":"86","author":"Dougherty","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaip.2023.06.035_bib83","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jaci.2022.09.027","article-title":"Scientific journey to the first FDA-approved drug for eosinophilic esophagitis","volume":"150","author":"Rothenberg","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib84","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.anai.2022.01.019","article-title":"Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use","volume":"128","author":"Spergel","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib85","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa2205982","article-title":"Dupilumab in adults and adolescents with eosinophilic esophagitis","volume":"387","author":"Dellon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.06.035_bib87","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.anai.2022.12.014","article-title":"Clinical guidance for the use of dupilumab in eosinophilic esophagitis: a yardstick","volume":"130","author":"Aceves","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.833728","article-title":"The inhibitory receptor siglec-8 interacts with Fc\u03b5RI and globally inhibits intracellular signaling in primary mast cells upon activation","volume":"13","author":"Korver","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000501637","article-title":"AK002, a humanized sialic acid\u2013binding immunoglobulin-like lectin-8 antibody that induces antibody-dependent cell-mediated cytotoxicity against human eosinophils and inhibits mast cell-mediated anaphylaxis in mice","volume":"180","author":"Youngblood","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib90","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.14309\/01.ajg.0000858424.48968.ad","article-title":"S446 Results from KRYPTOS, a phase 2\/3 study of lirentelimab (AK002) in adults and adolescents with EoE","volume":"117","author":"Dellon","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib92","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","article-title":"Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis","volume":"118","author":"Stein","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib93","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaip.2023.06.035_bib94","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa'ad","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib95","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib96","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.gastro.2014.05.036","article-title":"Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE","volume":"147","author":"Clayton","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib97","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2014.07.049","article-title":"Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis","volume":"135","author":"Rothenberg","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.06.035_bib98","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2023.06.035_bib99","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41395-018-0145-1","article-title":"The anti-\u03b14\u03b27 integrin therapeutic antibody for inflammatory bowel disease, vedolizumab, ameliorates eosinophilic esophagitis: a novel clinical observation","volume":"113","author":"Nhu","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2023.06.035_bib100","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.cgh.2018.06.022","article-title":"The potential role of vedolizumab in concomitant eosinophilic esophagitis and Crohn's disease","volume":"16","author":"Taft","year":"2018","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823007006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823007006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:38:29Z","timestamp":1761975509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823007006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":98,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2213219823007006"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.06.035","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Advances in the Treatment of Eosinophilic Esophagitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}